363250 — Genesystem Co Balance Sheet
0.000.00%
- KR₩42bn
- KR₩45bn
- KR₩1bn
Annual balance sheet for Genesystem Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9,060 | 37,631 | 26,489 | 17,400 | 7,623 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 865 | 2,099 | 582 | 281 | 229 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11,410 | 41,514 | 30,462 | 21,039 | 9,982 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,780 | 6,056 | 6,012 | 6,499 | 8,652 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 18,919 | 50,658 | 41,183 | 38,928 | 29,902 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,668 | 2,644 | 1,966 | 2,432 | 2,538 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,603 | 6,572 | 6,073 | 11,472 | 10,629 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 12,316 | 44,085 | 35,110 | 27,456 | 19,273 |
| Total Liabilities & Shareholders' Equity | 18,919 | 50,658 | 41,183 | 38,928 | 29,902 |
| Total Common Shares Outstanding |